Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose We aimed to determine the demographic and epidemiologic variables that are associated with no treatment in lung cancer patients. Materials and Methods Patient data were collected from the Korean National Health Insurance Database. The lung cancer group included patients with an initial diagnosis of lung cancer between January 2009 and December 2014. Treated cases were defined as those that underwent surgery, radiation, or chemotherapy until death, after the diagnosis of lung cancer. Risk of no treatment was calculated by multiple logistic regression analysis. Results Among the 2,148 new cases of lung cancer from 2009 to 2104, 612 (28.4%) were not treated. Risk of no treatment was higher in the following patients: patients in their 60s (odds ratio [OR], 1.18; 95% confidence interval [CI], 0.75 to 1.84), 70s (OR, 3.64; 95% CI, 2.41 to 5.50), and > 80 years old (OR, 16.55; 95% CI, 10.53 to 25.03) than those in their 50s; patients with previous myocardial infarction (OR, 2.07; 95% CI, 1.01 to 4.25) or chronic kidney disease (OR, 2.88; 95% CI, 1.57 to 5.30); and patients diagnosed at a non-referral hospital (OR, 1.40; 95% CI, 1.01 to 1.92) or primary care provider (OR, 1.81; 95% CI, 1.43 to 2.29) compared with referral hospital. Low-income patients receiving Medicaid were 1.75 times (95% CI, 1.14 to 2.68) more likely to forgo treatment than high-income patients (upper 20%). Risk was not associated with sex or the year in which the lung cancer was diagnosed. Conclusion Age predominantly determines whether patients with lung cancer undergo anti-cancer treatment.
Abstract
Purpose We aimed to determine the demographic and epidemiologic variables that are associated with no treatment in lung cancer patients. Materials and Methods Patient data were collected from the Korean National Health Insurance Database. The lung cancer group included patients with an initial diagnosis of lung cancer between January 2009 and December 2014. Treated cases were defined as those that underwent surgery, radiation, or chemotherapy until death, after the diagnosis of lung cancer. Risk of no treatment was calculated by multiple logistic regression analysis. Results Among the 2,148 new cases of lung cancer from 2009 to 2104, 612 (28.4%) were not treated. Risk of no treatment was higher in the following patients: patients in their 60s (odds ratio [OR], 1.18; 95% confidence interval [CI], 0.75 to 1.84), 70s (OR, 3.64; 95% CI, 2.41 to 5.50), and > 80 years old (OR, 16.55; 95% CI, 10.53 to 25.03) than those in their 50s; patients with previous myocardial infarction (OR, 2.07; 95% CI, 1.01 to 4.25) or chronic kidney disease (OR, 2.88; 95% CI, 1.57 to 5.30); and patients diagnosed at a non-referral hospital (OR, 1.40; 95% CI, 1.01 to 1.92) or primary care provider (OR, 1.81; 95% CI, 1.43 to 2.29) compared with referral hospital. Low-income patients receiving Medicaid were 1.75 times (95% CI, 1.14 to 2.68) more likely to forgo treatment than high-income patients (upper 20%). Risk was not associated with sex or the year in which the lung cancer was diagnosed. Conclusion Age predominantly determines whether patients with lung cancer undergo anti-cancer treatment.
참고문헌 (30)
- Thun MJ, "Cancer epidemiology and prevention", pp.519~541 (2018), Oxford University Press
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
- "SEER Cancer Stat Facts: Lung and Bronchus Cancer" (2018)[URL]
- 박지영, "Epidemiology of Lung Cancer in Korea: Recent Trends", Tuberculosis and Respiratory Diseases, 79(2), pp.58~69 (2016), 대한결핵및호흡기학회
- Small AC, "Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy", Cancer, 118, pp.5947~5954 (2012)
- David EA, "Increasing rates of no treatment in advanced-stage nonsmall cell lung cancer patients : a propensity-matched analysis", J Thorac Oncol, 12, pp.437~445 (2017)
- Huang HL, "Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan", PLoS One, 9, pp.e101731~ (2014)
- Mok TS, "Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma", N Engl J Med, 361, pp.947~957 (2009)
- Kwak EL, "Anaplastic lymphoma kinase inhibition in nonsmall-cell lung cancer", N Engl J Med, 363, pp.1693~1703 (2010)
- Borghaei H, "Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer", N Engl J Med, 373, pp.1627~1639 (2015)
- Garon EB, "Pembrolizumab for the treatment of non-small-cell lung cancer", N Engl J Med, 372, pp.2018~2028 (2015)
- Janne PA, "AZD9291 in EGFR inhibitor-resistant nonsmall-cell lung cancer", N Engl J Med, 372, pp.1689~1699 (2015)
- Temel JS, "Early palliative care for patients with metastatic non-small-cell lung cancer", N Engl J Med, 363, pp.733~742 (2010)
- Wang S, "Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans", J Clin Oncol, 30, pp.1447~1455 (2012)
- "Cancer incidence in Korea" (2016)[URL]
- Suh WN, "Risk factors associated with treatment refusal in lung cancer", Thorac Cancer, 8, pp.443~450 (2017)
- "Life expectancy increased by 5years since 2000, but health inequalities persist" (2016)[URL]
- Shingler SL, "Treatment preference, adherence and outcomes in patients with cancer : literature review and development of a theoretical model", Curr Med Res Opin, 30, pp.2329~2341 (2014)
- van Kleffens T, "Physicians' evaluations of patients' decisions to refuse oncological treatment", J Med Ethics, 31, pp.131~136 (2005)
- Puts MT, "Characteristics of older newly diagnosed cancer patients refusing cancer treatments", Support Care Cancer, 18, pp.969~974 (2010)
- Lin JH, "Predicting adherence to tamoxifen for breast cancer adjuvant therapy and prevention", Cancer Prev Res(Phila), 4, pp.1360~1365 (2011)
- 민혜숙, "Supporting Low-Income Cancer Patients: Recommendations for the Public Financial Aid Program in the Republic of Korea", Cancer Research and Treatment, 50(4), pp.1074~1083 (2018), 대한암학회
- Wallace SK, "Refusal of recommended chemotherapy for ovarian cancer : risk factors and outcomes; a national cancer data base study", J Natl Compr Canc Netw, 14, pp.539~550 (2016)
- Janssen-Heijnen ML, "Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer", Thorax, 59, pp.602~607 (2004)
- Marshall CA, "Un Abrazo Para La Familia : providing lowincome Hispanics with education and skills in coping with breast cancer and caregiving", Psychooncology, 22, pp.470~474 (2013)
- Turner D, "Partners and close family members of long-term cancer survivors: health status, psychosocial well-being and unmet supportive care needs", Psychooncology, 22, pp.12~19 (2013)
- Goulart BH, "Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer", J Oncol Pract, 9, pp.42~50 (2013)
- Murgu S, "Impact of a non-small cell lung cancer educational program for interdisciplinary teams", Chest, 153, pp.876~887 (2018)
- Dunn J, "Barriers to lung cancer care : health professionals' perspectives", Support Care Cancer, 25, pp.497~504 (2017)
- 박샘이나, "Current Trends of Lung Cancer Surgery and Demographic and Social Factors Related to Changes in the Trends of Lung Cancer Surgery: An Analysis of the National Database from 2010 to 2014", Cancer Research and Treatment, 49(2), pp.330~337 (2017), 대한암학회